Pain Therapeutics Inc. (Nasdaq: PTIE) reported positive results from a human abuse potential study of its late stage drug candidate REMOXY. Shares of the biopharmaceutical more than doubled by leaping $4.82 to closes at $9.04.
Positive study results for Pain Therapeutics
January 09, 2018 at 16:45 PM EST